HashiCorp, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HCP research report →
Range $31 – $54
Price Chart
About the company
HashiCorp, Inc. delivers comprehensive solutions for automating infrastructure across diverse cloud environments globally. A key offering is Terraform, an infrastructure provisioning tool that embraces an Infrastructure-as-Code (IaC) philosophy.
- CEO
- David McJannet
- IPO
- 2021
- Employees
- 2,200
- HQ
- San Francisco, CA, US
Get TickerSpark's AI analysis on HCP
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $7.11B
- P/E
- -35.49
- Fwd P/E
- 45.96
- PEG
- -0.58
- P/S
- 12.19
- P/B
- 5.56
- EV/EBITDA
- -35.32
- Div Yield
- 0.00%
- Gross Margin
- 81.36%
- Op Margin
- -43.61%
- Net Margin
- -32.70%
- ROE
- -15.77%
- ROIC
- -20.29%
Latest fiscal year · YoY change
- Revenue
- $583.14M+22.5%
- Gross Profit
- $474.44M+22.0%
- Op Income
- $-254,278,000
- Net Income
- $-190,668,000+30.5%
- EPS
- $-0.98+33.3%
- OCF Growth
- +87.2%
- FCF Growth
- +75.5%
- 52W High
- $34.84
- 52W Low
- $23.00
- 50D MA
- $34.27
- 200D MA
- $33.84
- Beta
- 1.19
- RSI (14)
- 71
- Avg Volume
- 3.24M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
HashiCorp beat Q4 guidance, saw improving renewal and pipeline trends, and guided for a fiscal 2025 revenue trough before a back-half recovery tied to cloud-first and product differentiation initiatives.· March 5, 2024
- Q4 revenue was $156 million, up 15% year over year, and HashiCorp said it exceeded both top- and bottom-line guidance.
- Non-GAAP remaining performance obligations were $483 million, up 21% year over year, with renewal rates and pipeline conversion improving versus Q3.
- Management said optimization pressures are abating, but some historical self-managed entitlement consumption is still weighing on renewals and revenue timing.
- The company is shifting enterprise land to Terraform Cloud, increasing commercial differentiation, and reallocating R&D toward cloud products.
- FY25 guidance calls for revenue of $643 million to $647 million and non-GAAP operating loss of $46 million to $43 million, with Q2 expected to be the revenue and cRPO trough and Q4 expected to reach non-GAAP operating income breakeven.
HashiCorp reported fourth-quarter fiscal 2024 revenue of $156 million, up 15% year over year, and non-GAAP remaining performance obligations of $483 million, up 21% year over year. Management said the quarter exceeded guidance on both the top and bottom line, and the company ended with another free cash flow positive quarter. For fiscal 2024, revenue grew 23% year over year. For fiscal 2025, management guided to revenue of $152 million to $154 million in Q1 and $643 million to $647 million for the full year, with non-GAAP operating loss of $19 million to $16 million in Q1 and $46 million to $43 million for the year. Gross margin is expected to remain in the low to mid 80% range, non-GAAP operating income breakeven is expected by Q4, and the company expects positive free cash flow in all quarters except Q2 due to seasonality.
Dave McJannet struck a candid but constructive tone, saying the company is “behind where we wanted” it to be in the growth cycle while also pointing to early signs of reengagement from large enterprises. He centered the strategy on three moves: simplifying go-to-market, widening commercial differentiation, and shifting more resources to HashiCorp-managed cloud offerings. He said the goal is to get back to 20% quarterly revenue growth in fiscal 2026, with the current fiscal year serving as the bridge.
Navam Welihinda highlighted a stronger-than-expected Q4, with 15% revenue growth, 23% full-year growth, and another free cash flow positive quarter. He said renewal rates, pipeline conversion, and sales-driven customer activity improved in Q4 versus Q3, and described FY25 as a “U-shaped recovery” with Q2 as the trough for revenue growth and CRPO growth, followed by improving back-half trends. He also said gross margins should stay in the low to mid 80% range, expenses will grow slower than revenue, and the board authorized a $250 million share repurchase program starting in fiscal 2025 because the company believes it has excess cash beyond operating and midterm M&A needs.
Analysts pressed on whether the cloud-first push for large enterprises is really gaining traction, and management said customer willingness and platform readiness have both improved, with enterprise cloud now the default motion for Terraform and sales compensation shifted to favor cloud land. Questions also focused on whether Q4 strength came from a better macro environment or better execution; management said it was both, citing easing optimization pressures and improved field execution. Other topics included security competition with Microsoft, where Armon Dadgar said Microsoft is more partner than competitor, and the impact of Terraform Stacks and LTS releases, which management said should strengthen commercial differentiation and renewals.
The bull case from this call is that enterprise optimization appears to be easing, and HashiCorp saw improving renewals, better pipeline conversion, and stronger Q4 bookings activity. Management is actively changing the product and sales motion to push more customers onto cloud, increase commercial differentiation, and improve long-term retention, while also authorizing a $250 million buyback to return excess capital.
The main bear case is that management still sees lingering entitlement consumption and says the company is not fully out of the optimization cycle, which is delaying revenue acceleration. FY25 guidance implies only modest growth near term, Q1 revenue is expected to be seasonally lower, and management said the real reacceleration depends on back-half execution and a recovery that is still in progress.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 69.0%
- Shares Outstanding
- 204.45M
- Float Shares
- 141.12M
of shares held by institutions
312 13F filers
Buy/sell ratio 7.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for HCP, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Earl BlumenauerHouse · OR03 | Buy | May 25, 18 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock Inc. | 6.23M | ▼ 146.06K |
| Caxton Associates LP | 1.09M | ▲ 803.98K |
| Ggv Capital LLC | 658.99K | 0 |
| Nuveen Asset Management, LLC | 573.90K | ▼ 17.72K |
| Eisler Capital (Uk) Ltd. | 236.16K | ▲ 236.16K |
| Cigogne Management SA | 203.81K | ▲ 203.81K |
| Credit Suisse AG/ | 113.34K | ▲ 11.46K |
| Eisler Capital (Us) LLC | 94.28K | ▲ 55.00K |
| Arena Investors LP | 31.79K | ▲ 31.79K |
| Flow State Investments, L.P. | 30.00K | ▲ 30.00K |
| Raymond James Financial Services Advisors, Inc. | 28.80K | ▲ 34 |
| Oracle Alpha Inc. | 18.17K | ▲ 2.41K |
Held by 13 ETFs
Biggest fund positions in HCP by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 27, 25 | Zarmi Sigal | sell | 54,416 |
| Feb 27, 25 | Zarmi Sigal | sell | 3,125 |
| Feb 27, 25 | Solomon Glenn | sell | 8,172 |
| Feb 27, 25 | Solomon Glenn | sell | 1,372 |
| Feb 27, 25 | Solomon Glenn | sell | 346,599 |
| Feb 27, 25 | HENSHALL DAVID J | sell | 27,879 |
| Feb 27, 25 | HENSHALL DAVID J | sell | 1,458 |
| Feb 27, 25 | Ford Todd R | sell | 2,058 |
| Feb 27, 25 | Ford Todd R | sell | 50,000 |
| Feb 27, 25 | Ford Todd R | sell | 69,334 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our HCP coverage
Recent articles, reports, and earnings notes.
No research on HCP yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HCP report →More than 75% of Leqembi®-treated patients remained stable and nearly 7% improved over an average of 17 months of treatment in real-world LEADER study data presented at AAIC® 2026
gurufocus.com · Jul 14
LEQEMBI® Real-World LEADER Study Presented at AAIC® 2026 Finds Over 75% of Early Alzheimer's Patients Enrolled in the Study Remained Stable and Nearly 7% Improved Over an Average of 17 Months of Treat
gurufocus.com · Jul 14
Applied Biomics Launches New Antigen Affinity Purified HCP Antibody with 95% Coverage
businesswire.com · Jun 24
Critical Infrastructure Technologies Provides an Update to its Executed Letter of Intent with H. Cegielski - Poznan S.A.
thenewswire.com · Jun 4
Vercel Appoints Mitchell Hashimoto, Co-Founder of HashiCorp and Creator of Terraform, to Board of Directors
businesswire.com · Mar 18
Critical Infrastructure Technologies Executes a Letter of Intent with H. Cegielski - Poznan S.A.
thenewswire.com · Feb 18
IBM Shares Rise After Jefferies Upgrade to Buy on AI Momentum
gurufocus.com · Jan 5
Vercel Appoints Susan St. Ledger, former President of Worldwide Field Operations at HashiCorp, to Board of Directors
businesswire.com · Dec 17
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.